Late Adult Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Clinical Characterization and Predictors of Outcome (P7-8.005)
Alessandro Dinoto(University of Verona), Eoin P. Flanagan, Nisa Vorasoot(Mayo Clinic), Stephanie B. Syc‐Mazurek(Mayo Clinic), Eric Eggenberger(Michigan State University), Smathorn Thakolwiboon(Wheaton Franciscan Healthcare), Cristina Gutiérrez Valencia(WinnMed), Deena Tajfirouz(Anna Needs Neuroblastoma Answers), Nanthaya Tisavipat, Vyanka Redenbaugh(Mayo Clinic), Susan Horsman(WinnMed), Kevin D. Chodnicki(Mayo Clinic), Sean J. Pittock(Mayo Clinic), Kai Guo(Shaanxi Provincial People's Hospital), John Chen(Ankara Spine Center), Jan‐Mendelt Tillema, Laura Cacciaguerra(Mayo Clinic), Alfonso Lopez(WinnMed), Misha Pless
Cited by 1
Related Papers
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
Revised diagnostic criteria for neuromyelitis optica
|Neurology|2006|2.6k
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
|The Journal of Experimental Medicine|2005|2.3k
The spectrum of neuromyelitis optica
|The Lancet Neurology|2007|2.2k
Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis
|Annals of Neurology|2018|758